EMEA-001853-PIP01-15-M01

Key facts

Invented name
Active substance
Human normal immunoglobulin
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0380/2017
PIP number
EMEA-001853-PIP01-15-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of primary immunodeficiency
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Grifols Therapeutics Inc.
Tel. +49 69660593405
E-mail: bernhard.lauven@grifols.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating